Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
Immunological Medicine
Volume 46, 2023 - Issue 2
Original Article
Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort
Ryu Watanabea Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-1089-5296View further author information
https://orcid.org/0000-0002-1089-5296View further author information, Kosaku Murakamib Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0001-5981-4648View further author information
https://orcid.org/0000-0001-5981-4648View further author information, , Hiromu Itod Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan;e Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan;f Department of Orthopaedic Surgery, Kurashiki Central Hospital, Kurashiki, Japanhttps://orcid.org/0000-0002-1827-382XView further author information
https://orcid.org/0000-0002-1827-382XView further author information, Koichi Muratad Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan;e Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0002-7896-3937View further author information
https://orcid.org/0000-0002-7896-3937View further author information, , Takayuki Fujiid Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan;e Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0002-6556-1226View further author information
https://orcid.org/0000-0002-6556-1226View further author information, , Akira Onishid Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0002-3120-1273View further author information
https://orcid.org/0000-0002-3120-1273View further author information, Masao Tanakad Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0002-8942-2933View further author information
https://orcid.org/0000-0002-8942-2933View further author information, Akio Morinobuh Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japanhttps://orcid.org/0000-0002-4672-638XView further author information
https://orcid.org/0000-0002-4672-638XView further author information & Motomu Hashimotoa Department of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japanhttps://orcid.org/0000-0002-9241-060XView further author information
https://orcid.org/0000-0002-9241-060XView further author information show all